Given the multiple clinical phenotypes and subtypes that are observed with systemic sclerosis, what therapeutic approaches are aligned with what forms of the disease? And what is the evidence-based role for ECP?

Given the multiple clinical phenotypes and subtypes that are observed with systemic sclerosis, what therapeutic approaches are aligned with what forms of the disease? And what is the evidence-based role for ECP?

CLICK HERE FOR CME CREDIT

Given the multiple clinical phenotypes and subtypes that are observed with systemic sclerosis, what therapeutic approaches are aligned with what forms of the disease? And what is the evidence-based role for ECP?

Created by

CMEducation Resources IQ&A Extracorporeal Photopheresis Intelligence Zone | The Multi-Specialty Perspective

Presenter

Ian Odell, MD, PhD

Ian Odell, MD, PhD

Ian Odell, MD, PhD
Assistant Professor
Dermatology Director, Adult Primary Care Center
Scleroderma and Myositis Program
Yale University School of Medicine